Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Astera Labs, Inc. Director's Dealing 2024

Nov 18, 2024

30120_dirs_2024-11-18_9ac2d598-845a-4cb2-8387-896c02a1b2b2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Astera Labs, Inc. (ALAB)
CIK: 0001736297
Period of Report: 2024-11-14

Reporting Person: Tate Michael Truett (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-11-14 Common Stock A 694 $30.60 Acquired 293822 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1762888 Indirect

Footnotes

F1: These shares were acquired under the Astera Labs, Inc. 2024 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F2: These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.